Merck & Co Inc. Blog | Talkmarkets

Latest Posts

5 Deep Value Dividend Stocks For Annual Portfolio Rebalancing

Article By: SureDividend

Friday, February 26, 2021 7:53 PM EST

Buying stocks with high dividend yields is good–buying undervalued dividend stocks with growth potential is even better.

In this article: BMY, LAZ, LMT, MRK, TDS

Read

Merck To Acquire Pandion Therapeutics For $60 Per Share In Cash

Article By: The Fly

Thursday, February 25, 2021 8:45 AM EST

Merck and Pandion Therapeutics announced that the companies have entered into a definitive agreement, under which Merck, through a subsidiary, will acquire Pandion.

In this article: MRK, PAND

Read

Merck Ends Work On COVID-19 Vaccines, Still Working On Therapeutic Candidates

Article By: The Fly

Monday, January 25, 2021 8:36 AM EST

Merck announced that the company is discontinuing the development of its SARS-CoV-2/COVID-19 vaccine candidates, V590 and V591.

In this article: MRK

Read

E Merck: This Pharmaceutical Giant Has Significant Upside Potential

Article By: SureDividend

Friday, January 8, 2021 9:42 PM EST

Merck is a highly profitable dividend stock with a long runway of growth up ahead. With a reasonable valuation and a solid 3% yield, the stock is a buy.

In this article: MRK Also: AZN, PFE, MRNA

Read

Dogs Of The Dow 2021

Article By: Dividend Power

Wednesday, January 6, 2021 7:19 PM EST

The Dogs of the Dow is an investing strategy that is by now fairly well-known to many small investors. The 10 stocks from the Dow 30 that have the highest yield on the last day of the year comprise the Dogs for the Dow for the following year.

In this article: DOW, IBM, KO, MMM, MRK, VZ, AMGN, CSCO, WBA

Read

All Posts